These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. R. Michael Blaese: still blazing a path of his own. Jenks S J Natl Cancer Inst; 1998 Aug; 90(16):1188-91. PubMed ID: 9719076 [No Abstract] [Full Text] [Related]
10. Human gene therapy. Morgan RA; Anderson WF Annu Rev Biochem; 1993; 62():191-217. PubMed ID: 8352589 [No Abstract] [Full Text] [Related]
12. Adenosine deaminase deficiency: a model system for human somatic cell gene correction therapy. Vega MA Biochim Biophys Acta; 1992 Apr; 1138(4):253-60. PubMed ID: 1562612 [No Abstract] [Full Text] [Related]
13. Gene therapy: lessons learnt from the past decade. Interview by Clare Thompson. Morgan RA; Blaese RM BMJ; 1999 Nov; 319(7220):1310. PubMed ID: 10559061 [No Abstract] [Full Text] [Related]
14. [Possibilities and perspectives of genetic engineering in management of genetic diseases, neoplasms and AIDS]. Nowak J Pol Arch Med Wewn; 1993 May; 89(5):418-23. PubMed ID: 8367377 [No Abstract] [Full Text] [Related]
16. Treatment of patients with severe combined immunodeficiency due to adenosine deaminase (ADA) deficiency by autologous transplantation of genetically modified bone marrow cells. Hoogerbrugge PM; Vossen JM; v Beusechem VW; Valerio D Hum Gene Ther; 1992 Oct; 3(5):553-8. PubMed ID: 1420454 [No Abstract] [Full Text] [Related]
17. Genetic pharmacomodulation of nucleoside analogues and gene therapy for AIDS and cancer. Guettari N; Loubière L; Caruso M; Klatzmann D Antibiot Chemother (1971); 1996; 48():198-204. PubMed ID: 8726526 [No Abstract] [Full Text] [Related]
18. Gene therapy for severe combined immunodeficiency caused by adenosine deaminase deficiency: improved retroviral vectors for clinical trials. Onodera M; Nelson DM; Sakiyama Y; Candotti F; Blaese RM Acta Haematol; 1999; 101(2):89-96. PubMed ID: 10202239 [TBL] [Abstract][Full Text] [Related]